Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
The stock fell short of the S&P 500, which registered a gain of 0.12% for the day. At the same time, the Dow added 0.52%, and the tech-heavy Nasdaq lost 0.23%. The world's largest biotech drugmaker's stock has climbed by 1.38% in the past month, exceeding the Medical sector's loss of 2.25% and the S&P 500's loss of 3.45%. The investment community will be closely monitoring the performance of Amgen in its forthcoming earnings report. The company is expected to report EPS of $5.02, up 6.58% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $8.85 billion, up 7.92% from the prior-year quarter. Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Amgen Set to Report Q4 Earnings: Is a Beat in the Cards? [Yahoo! Finance]Yahoo! Finance
- EUROPEAN COMMISSION APPROVES BLINCYTO® IN PHILADELPHIA CHROMOSOME-NEGATIVE CD19-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN THE CONSOLIDATION PHASEPR Newswire
- Is Cutting DEI Deadly? FDA Stops Diversity Guidance In Clinical Trials [Forbes]Forbes
- Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Citigroup Inc. from $310.00 to $295.00. They now have a "neutral" rating on the stock.MarketBeat
- Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $324.00 price target on the stock.MarketBeat
AMGN
Earnings
- 10/30/24 - Beat
AMGN
Sec Filings
- 12/6/24 - Form 4
- 12/3/24 - Form 4
- 11/6/24 - Form 4
- AMGN's page on the SEC website